Ushpal Thind, an experienced mechanical engineer, has joined Graphene Enabled Systems Ltd, The University of Manchester’s graphene and 2D materials commercialisation business.
Previously a test engineer for the micro-CHP and utilities business, Flow Products, based in Capenhurst Cheshire, Ushpal brings a wealth of experience in industrial product design and manufacturing know-how.
Ushpal will work closely with the academic teams at the University, industrial partners, suppliers and customers. As well as being an experienced design engineer, Ushpal has an MSc in Materials Science and Engineering from Delft University of Technology in the Netherlands and a BEng in Mechanical Engineering from Imperial College London.
Graphene Enabled Systems Ltd, which is headquartered on Grafton Street in Manchester, is owned by the University. The new company’s mission is to create a number of highly profitable ‘spin-off’ businesses based on the University’s graphene patents. The University expects that many of these future ‘spin-off’ businesses will be based in and around Manchester, creating new jobs in the region and benefiting the local economy.
Using the University’s patents and working closely with scientists, Graphene Enabled will seek out new markets for graphene-based products. Once these markets have been identified, Graphene Enabled will create high-quality product prototypes which will showcase the technology to potential industrial partners and customers.
As an important part of the University’s graphene strategy, Graphene Enabled works in close collaboration with the University’s research teams, innovation and IP groups (UMI3 and UMIP), the National Graphene Institute (NGI) and, in 2018 and beyond, the new Graphene Engineering Innovation Centre (GEIC).
Andrew Wilkinson, Graphene Enabled’s CEO, commented: “We are very excited that Ushpal has joined us. His experience in product design and industrialisation will help to create high quality product demonstrators and prototypes capable of exciting customers in a wide range of markets and applications. In the coming months we will continue to build our engineering team, enabling us to accelerate the pace at which we bring new product concepts to market.”
For further information about Graphene Enabled, please visit our website www.graphene-enabled.com and follow us on Twitter @GrapheneEnabled.
(From left to right: Dr Bianca Price, Professor Curtis Dobson and Dr Nishal Govindji-Bhatt)
Around 400 people from the Northwest’s biomedical sector gathered on 24th November at the 15th Northwest Biomedical Awards at Mere Golf and Country Club, Cheshire. This prestigious awards dinner celebrates key achievements from companies and individuals who have made a significant contribution to the biomedical sector during 2016. The evening was hosted by comedian and broadcaster Paul Sinha, one of the stars of the ITV quiz The Chase.
University of Manchester spin-out, MicroBiosensor Ltd, won the Bionow Healthcare Project of the Year Award for their InfectDetect project. The company, which spun-out of the Medical Device Biology Group in the Division of Pharmacy and Optometry, has devised and manufactured a prototype simple novel antimicrobial susceptibility diagnostic to prevent hospital admission due to urinary tract infection. The new project, led by Dr Nishal-Govindji-Bhatt and Dr Duncan Henderson, should provide appreciable savings to the NHS, impact the rise of antimicrobial resistance, as well as reduce suffering in vulnerable clinical populations. The award was sponsored by TRUSTECH.
Professor Curtis Dobson, Chairman and Founder of MicroBiosensor, comments: ”It was fantastic news for Microbiosensor to win this Award, which recognises the dramatic progress we have made this year in developing a second product featuring our exciting proprietary technology. Microbiosensor now has two high quality products nearing a CE Mark, and these are poised to have a major global impact, both delivering significant savings for the healthcare providers and improving patient outcomes.”
University of Manchester Research Fellow Dr Bianca Price (who is also based in the Medical Device Biology Group) won the Bionow Promising Technologist of the Year Award for her work in creating an innovative ‘infected wound in a dish’. The model has evaluated anti-infective products from different industrial collaborators, including a novel wound filler and antimicrobial dressings. The award was sponsored by Seqirus.
Dr Price comments: “It is wonderful to be acknowledged for innovative work that has real world impact in this way. The model developed in the Medical Device Biology Group has generated lots of interest in the wound care sector as a relevant way to test movement and efficacy of antimicrobials released from medical devices. We will continue to develop and apply this model as well as other complimentary approaches over the coming years.”
Congratulations also go to colleagues at the Greater Manchester Academic Health Science Network for winning the Bionow Business Services Award, sponsored by Skills and Growth Company.
To cap the night off, University spin-out, F2G Ltd, won the Bionow Investment Deal of the Year Award for their $60M financing round. F2G is an established Manchester-based specialist antifungal company developing a completely new class of antifungal agents to treat life threatening invasive fungal infections. The award was sponsored by QIAGEN Manchester.
The complete list of winners is as follows:
The 2016 winners are:
- Bionow Start Up of the Year Award – Aptus Clinical – Sponsored by RSM
- Bionow Healthcare Project of the Year Award – MicroBiosensor – Sponsored by TRUSTECH
- Bionow Project of the Year Award – Cobra Biologics- Sponsored by Waters Corporation
- Bionow Product of the Year Award – Magnesium Elektron – Sponsored by Innovation Agency
- Bionow Technical Service Award – Perfectus Biomed – Sponsored by Appleyard Lees
- Bionow Business Services Award – Greater Manchester Academic Health Science Network – Sponsored by Skills and Growth Company
- Bionow Promising Technologist of the Year Award – Dr Bianca Price – Sponsored by Seqirus
- Bionow Investment Deal of the Year Award – F2G Ltd – Sponsored by QIAGEN Manchester
- Bionow Outstanding Contribution Award – Alan Boyd- -Sponsored by Sci-Tech Daresbury
- Bionow Company of the Year Award – Shield Therapeutics – Sponsored by AstraZeneca
For more information about Bionow, please visit www.bionow.co.uk
The Bionow Awards Dinner was sponsored by Manchester Science Partnerships, Appleyard Lees, CY Partners, Redx Pharma and World Courier.
We are seeking to inspire the next generation of individuals or teams with entrepreneurial ideas:
- Are you currently working or studying at AMBS or a recent graduate?
- Is your idea likely to be an entrepreneurial or innovative solution to a business, societal or environmental problem?
Funding from £500 – £2000 is available, for individuals to try out or grow their entrepreneurial ideas. This might mean finding out if your idea is viable, learning more about what is needed to develop the idea by testing the project on a small scale, right through to more robust road-testing of the idea. We also provide one to one support to assist you with your applications and informative workshops for successful applicants.
The funding opportunity provided by UMIP and MEC is open to all AMBS members of staff, research students (inc. DBA, MBA) and recent graduates (graduated within the last 2 years).
- Closing date for applications is Friday 20th January 2017
- Successful applicants will be informed by Friday 3rd February 2017
Contact firstname.lastname@example.org * for further information and to receive an application form
*Please provide your full contact details, job title or student status and a brief outline of your idea